Scientists and parents involved with a pioneering childhood cancer charity recently came together to discuss the future of research into the childhood cancer rhabdomyosarcoma, from its genetic causes to treatment innovations. A promising new project - co-designed by researchers and families - will now mine hundreds of biobank samples to understand the genomic and demographic factors governing how a child responds to treatment.